Argent Trust’s AbbVie ABBV Stock Holding History

Argent Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$4.54M	Sell	48,003 -2,395	-5%	-$263K	1.24%	21
2017 Q4	$4.87M	Sell	50,398 -5,388	-10%	-$508K	1.3%	19
2017 Q3	$4.96M	Buy	55,786 +432	+0.8%	+$32.9K	1.36%	17
2017 Q2	$4.01M	Buy	55,354 +1,586	+3%	+$107K	1.12%	23
2017 Q1	$3.5M	Buy	53,768 +853	+2%	+$53.6K	0.99%	28
2016 Q4	$3.31M	Sell	52,915 -775	-1%	-$47.3K	0.96%	27
2016 Q3	$3.39M	Buy	53,690 +5,491	+11%	+$355K	1.03%	25
2016 Q2	$2.98M	Buy	48,199 +1,969	+4%	+$120K	0.93%	30
2016 Q1	$2.64M	Buy	46,230 +12,886	+39%	+$718K	0.85%	34
2015 Q4	$1.98M	Buy	+33,344	New	+$1.92M	0.65%	42

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Argent Trust's ABBV Position: Q1 2018 in Review

Argent Trust reduced its AbbVie (ABBV) stake by 4.8% in Q1 2018, selling an estimated $263K and leaving 48,003 shares worth $4.54M. The position accounts for 1.24% of the portfolio, ranked #21.

Argent Trust first reported a position in ABBV in Q4 2015 and has held it in 10 quarters since. The position peaked at $4.96M in Q3 2017. 2,015 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Argent Trust held 48,003 shares of AbbVie worth $4.54M as of Q1 2018.
Argent Trust sold 2,395 AbbVie shares in Q1 2018, an estimated $263K.
AbbVie made up 1.24% of Argent Trust's portfolio in Q1 2018, its #21 holding.
Argent Trust first reported a position in AbbVie in Q4 2015 and has held it in 10 quarters since.
Argent Trust's AbbVie position peaked at $4.96M in Q3 2017.
2,015 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.